Moby1d agoneutral
Codexis, Inc. Q1 2026 Earnings Call SummaryMoby summary of Codexis, Inc.'s Q1 2026 earnings call
News
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
187last 24h
1886last 7d
373🟢 bullish (7d)
178🔴 bearish (7d)
114publishers
MarketBeat1d agoneutral
Codexis Q1 Earnings Call HighlightsCodexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis enzymatic manufacturing platform for RNA medicines and reiterated full-year revenue guidance of $72 million
